The chief scientific officer of FibroBiologics discussed the advantages of fibroblast cell therapy over stem cell therapy.
Neurology
Latest News
Advertisement
CME Content
Advertisement
Positive results from a phase 1/2 study of AXO-AAV-GM1 were presented at WORLDSymposium.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in gene and cell therapies.
SwanBio previously presented positive preclinical data at the ESGCT 2021 meeting.
The positive news is countered by a report of a patient death in Taysha’s gene therapy program for GM2 gangliosidosis.
Review top news and interview highlights from the week ending January 28, 2022.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in gene and cell therapies.
Investigators from IRCCS San Raffaele analyzed results from a phase 1/2 study on atidarsagene autotemcel.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in gene and cell therapies.
Eli-cel remains on clinical hold in cerebral adrenoleukodystrophy after a report of persistent anemia.
Review top news and interview highlights from the week ending January 14, 2022.
Many cell and gene therapy companies are initiating new programs and collaborations with the start of the new year.
The placebo crossover cohort experienced statistically significant improvements in NSAA score over external control.
Review top news and interview highlights from the week ending January 7, 2022.
The DSMB has recommended that enrollment expand and doses be escalated from 3.3 to 5 mg in 1 cohort of the KIK-AS study.
Data from a phase 1/2 trial of AMT-130 supports continued enrollment for a higher-dose cohort of 6 x 1013 vg.
The director of the Buffalo Neuroimaging Analysis Center and professor of Universtiy of Buffalo discussed avenues of research into reversing neurodegeneration in MS.
Review some of our most-viewed coverage of advancements in cell therapies, including the latest study results and insights from experts in the field.
Review top news and interview highlights from the week ending December 24, 2021.
The program is still on clinical hold following SUSARs of myelodysplastic syndrome in treated participants.
The FDA has placed the investigational new drug application for the treatment on clinical hold.
Review top news and interview highlights from the week ending December 17, 2021.
Review top news and interview highlights from the week ending December 9, 2021.
Autologous adipose stem cell data in a small cohort provides a feasibility for future validation studies.
Advertisement
Advertisement
Trending on CGTlive®
1
FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy Shows Promise for Multiple Myeloma
2
Crawford Strunk, MD, on Integrating Gene Therapy into Clinical Care for Sickle Cell Disease
3
Crawford Strunk, MD, on the Importance of Palliative Care in Sickle Cell Disease
4
The Importance of Palliative Care in Sickle Cell Disease
5
